Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (141-150 of 301) with videos related to

Pageof 31
Sort By:
International Journal of Cancer|January 15, 1980
Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumorM J Rogers, L W Law, M A Pierotti, et al.
Cancer Research|June 1, 1991
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-mybC Melani, L Rivoltini, G Parmiani, et al.
The Journal of Experimental Medicine|August 4, 1999
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cellsZ Wang, F M Marincola, L Rivoltini, et al.
Transplantation Proceedings|December 1, 1981
Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k originM J Rogers, G Carbone, D Ballinari, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cellsP A Ruffini, L Rivoltini, A Silvani, et al.
International Journal of Cancer|December 15, 1986
Control of human melanoma growth in nude mice by autologous allo-activated peripheral blood lymphocytesA Balsari, G Tona, M P Colombo, et al.
International Journal of Cancer|October 15, 1988
Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx)C Gambacorti-Passerini, L Rivoltini, R Supino, et al.
Biochimica Et Biophysica Acta|July 8, 1987
Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytesG Parmiani, L Grazioli, M Sensi, et al.
Nucleic Acids Research|September 25, 1989
A TaqI RFLP at the gas-2 locusM P Colombo, P Baracetti, G Cairo, et al.
Cancer Research|May 15, 1987
Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamideC Gambacorti-Passerini, M Radrizzani, E Erba, et al.
Pageof 31

Showing results (141-150 of 301) with videos related to

Sort By:
Pageof 31
International Journal of Cancer|January 15, 1980
Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumorM J Rogers, L W Law, M A Pierotti, et al.
Cancer Research|June 1, 1991
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-mybC Melani, L Rivoltini, G Parmiani, et al.
The Journal of Experimental Medicine|August 4, 1999
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cellsZ Wang, F M Marincola, L Rivoltini, et al.
Transplantation Proceedings|December 1, 1981
Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k originM J Rogers, G Carbone, D Ballinari, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cellsP A Ruffini, L Rivoltini, A Silvani, et al.
International Journal of Cancer|December 15, 1986
Control of human melanoma growth in nude mice by autologous allo-activated peripheral blood lymphocytesA Balsari, G Tona, M P Colombo, et al.
International Journal of Cancer|October 15, 1988
Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx)C Gambacorti-Passerini, L Rivoltini, R Supino, et al.
Biochimica Et Biophysica Acta|July 8, 1987
Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytesG Parmiani, L Grazioli, M Sensi, et al.
Nucleic Acids Research|September 25, 1989
A TaqI RFLP at the gas-2 locusM P Colombo, P Baracetti, G Cairo, et al.
Cancer Research|May 15, 1987
Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamideC Gambacorti-Passerini, M Radrizzani, E Erba, et al.
Pageof 31